Table 3.
Endogenous thrombin potential | ||||||
---|---|---|---|---|---|---|
Control | Asthma | |||||
β | 95% CI | R 2 | β | 95% CI | R 2 | |
Age, years | 0.4 | 0.03 | −0.05 to 0.11 | 0.37 | ||
Body mass index, kg/m2 | 0.16a | 0.01 to 0.31 | 0.2a | 0.12 to 0.28 | ||
FEV1/VC | –0.09a | −0.17 to −0.01 | ||||
Blood platelet count, 103/μl | 0.17a | 0.09 to 0.25 | ||||
Total cholesterol, mmol/l | 0.16a | 0.08 to 0.24 | ||||
Factor II, % | 0.38a | 0.23 to 0.53 | 0.19a | 0.12 to 0.26 | ||
hsCRP, mg/l | 0.15 | −0.01 to 0.31 | 0.13a | 0.03 to 0.23 | ||
Immunoglobulin E (log10), IU/ml | 0.26a | 0.12 to 0.40 | ||||
Interleukin 6, pg/ml | 0.01 | −0.16 to 0.18 | 0.17a | 0.08 to 0.26 | ||
Tumor necrosis factor α, pg/ml | 0.07 | −0.08 to 0.22 | 0.04 | −0.04 to 0.12 | ||
Periostin, ng/ml | 0.02 | −0.06 to 0.1 | ||||
α2-macroglobulin, nmol/l | 0.30a | 0.14 to 0.45 | 0.34a | 0.27 to 0.41 | ||
Plasminogen, % | 0.09a | 0.02 to 0.16 | ||||
Platelet factor 4, ng/ml | 0.01 | −0.06 to 0.8 | ||||
Adjustment statistics | F = 3.29, p = 0.009 | F = 6.9, p < 0.001 | ||||
Clot lysis time | ||||||
Control | Asthma | |||||
β | 95% CI | R 2 | β | 95% CI | R 2 | |
FEV1/VC | 0.51 | −0.11a | −0.19 to −0,03 | 0.25 | ||
Blood platelet count, 103/μl | 0.14a | 0.01 to 0.27 | ||||
White blood cells, 103/μl | 0.15a | 0.03 to 0.27 | 0.01 | −0.07 to 0.09 | ||
Total cholesterol, mmol/l | 0.13a | 0.01 to 0.25 | 0.15a | 0.07 to 0.23 | ||
Triglycerides, mmol/l | 0.19a | 0.16 to 0.31 | ||||
Glucose, mmol/l | 0.2a | 0.06 to 0.34 | ||||
hsCRP, mg/l | −0.21a | −0.35 to −0.07 | 0.08 | −0.02 to 0.18 | ||
Immunoglobulin E (log10), IU/ml | −0.23a | −0.31 to −0.15 | ||||
Antithrombin, % | −0.11a | −0.19 to −0,03 | ||||
ETP, nmol/l thrombin x min. | −0.21a | −0.33 to −0.09 | 0.17a | 0.12 to 0.26 | ||
Plasminogen, % | 0.2a | 0.08 to 0.32 | 0.06 | −0.02 to 0.14 | ||
Interleukin 6, pg/ml | −0.002 | −0.152 to 0.148 | −0.05 | −0.15 to 0.05 | ||
Tumor necrosis factor α, pg/ml | 0.31a | 0.16 to 0.46 | 0.15a | 0.07 to 0.23 | ||
Periostin, ng/ml | 0.04 | −0.04 to 0.12 | ||||
Antiplasmin, % | 0.3a | 0.17 to 0.43 | ||||
Plasminogen activator inhibitor-1, ng/ml | 0.35a | 0.22 to 0.48 | 0.28a | 0.2 to 0.36 | ||
P-selectin, ng/ml | −0.26a | −0.4 to −0.12 | −0.2a | −0.28 to −0.12 | ||
Adjustment statistics | F = 4.2, p = 0.0006 | F = 4.37, p < 0.001 |
The resulting standardized regression coefficient (β) (with 95% confidence intervals [95% CI]) for a factor (independent variable) indicates the increase/decrease in standard deviations (SDs) of dependent variable, when that particular factor increases with 1 SD and all other variables in the model are unchanged
FEV 1 /VC forced expiratory volume in 1 s/vital capacity, hsCRP high-sensitivity C-reactive protein, ETP endogenous thrombin potential
aStatistically significant